6533b7ddfe1ef96bd1275485
RESEARCH PRODUCT
Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.
Angelica Lindén HirschbergAntonio CanoRisto ErkkolaPatrice LopesVasilios KarageorgiouIannis M. ZervasAreti C. SpyropoulouIrene LambrinoudakiFatih DurmusogluDimitrios G. GoulisIuliana CeausuLudwig KieselJohannes BitzerMick Van TrotsenburgAmos PinesMargaret ReesPeter ChedrauiPetra Stutesubject
Position statementAdultComplementary Therapiesmedicine.medical_specialtyPeriMenopausal Hormone TherapyGeneral Biochemistry Genetics and Molecular BiologyEMAS03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineModel of CarePsychiatryEarly MenopauseLife StyleDepressive symptomsDepression (differential diagnoses)Societies MedicalAgedDepressive Disorder Major030219 obstetrics & reproductive medicinePostmenopausal womenVasomotorbusiness.industryDepressionObstetrics and GynecologyMenopausal TransitionMiddle AgedAntidepressive AgentsHormones3. Good healthPerimenopauseEuropePostmenopauseTreatment OutcomePractice Guidelines as TopicFemaleMenopausal hormone therapyMenopausebusinessPsychosocialdescription
Introduction: Globally, the total number of people with depression exceeds 300 million, and the incidence rate is 70 % greater in women. The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes. Aim: The aim of this position statement is to provide a comprehensive model of care for the management of depressive symptoms in perimenopausal and early menopausal women, including diagnosis, treatment and follow-up. The model integrates the care provided by all those involved in the management of mild or moderate depression in midlife women. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: Awareness of depressive symptoms, early detection, standardized diagnostic procedures, personalized treatment and a suitable follow-up schedule need to be integrated into healthcare systems worldwide. Recommended treatment comprises antidepressants, psychosocial therapies and lifestyle changes. Alternative and complementary therapies, although widely used, may help with depression, but a stronger evidence base is needed. Although not approved for this indication, menopausal hormone therapy may improve depressive symptoms in peri- but not in postmenopausal women, especially in those with vasomotor symptoms. Sistema de Investigation y Desarrollo (SINDE) Vice-Rectorado de Investigacion & Postgrado (VRIP) of the Universidad Catolica de Santiago de Guayaquil
year | journal | country | edition | language |
---|---|---|---|---|
2019-11-20 | Maturitas |